Today: 4 March 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Opendoor Technologies (OPEN) Stock Today: Meme Rally, AI Pivot and 2026 Forecasts – December 8, 2025

Opendoor Technologies (OPEN) Stock Today: Meme Rally, AI Pivot and 2026 Forecasts – December 8, 2025

Opendoor shares closed at $7.15 on Dec. 5, up over 350% year-to-date from $1.60, despite continued losses and recent dilution. Q3 2025 revenue fell 33% to $915 million, with a net loss of $90 million. Wall Street’s 12-month price targets remain far below current levels, clustering between $1.70 and $2.90. Trading volume and search interest have surged amid meme stock activity.
D-Wave Quantum (QBTS) Stock on December 8, 2025: Government Pivot, Qubits 2026 and Bubble Warnings Collide

D-Wave Quantum (QBTS) Stock on December 8, 2025: Government Pivot, Qubits 2026 and Bubble Warnings Collide

D-Wave Quantum (NYSE: QBTS) traded near $28 intraday on December 8, up over 3%, with its market cap approaching $9.7 billion despite ongoing losses and modest revenue. The stock has soared from a 52-week low of $2.50 to a high of $46.75 in 2025, posting extreme volatility and over 200% annual gains. D-Wave announced its Qubits 2026 user conference for January in Boca Raton, Florida.
8 December 2025
Canada’s F‑35 Crossroads: Quebec Maintenance Hub, Leaked Scorecard and a Last‑Minute Gripen Push

Canada’s F‑35 Crossroads: Quebec Maintenance Hub, Leaked Scorecard and a Last‑Minute Gripen Push

A leaked Department of National Defence chart shows the F-35 scored 95% against the Swedish Gripen’s 33% in Canada’s fighter jet competition. L3Harris MAS is pushing to make Mirabel, Quebec a major F-35 maintenance hub, with plans to service over 2,000 jets if Canada commits to the full F-35 order. The project could cost $200 million and affect 5,000 jobs. Prime Minister Mark Carney is nearing a final decision.
8 December 2025
Netflix (NFLX) Stock on December 8, 2025: Warner Bros Mega-Deal, Trump Scrutiny and 2026 Forecasts Explained

Netflix (NFLX) Stock on December 8, 2025: Warner Bros Mega-Deal, Trump Scrutiny and 2026 Forecasts Explained

Netflix shares fell about 4% Monday after news of its $72 billion bid for Warner Bros. Discovery’s studio and streaming assets and a hostile counter-offer from Paramount Skydance. The deal, announced December 5, would give Netflix control of Warner’s studios, HBO, and major IP, but exclude CNN and Discovery networks. President Trump signaled concerns over market concentration, saying he “will be involved” in the merger review.
8 December 2025
UK Mortgage Rates Hit Pre‑Mini‑Budget Lows as China’s $1 Trillion Trade Surplus Shifts the Global Outlook

UK Mortgage Rates Hit Pre‑Mini‑Budget Lows as China’s $1 Trillion Trade Surplus Shifts the Global Outlook

UK mortgage rates have dropped to their lowest since September 2022, with typical two-year fixes at 4.86% and five-year deals at 4.91%, according to Moneyfacts. Major lenders have cut prices, sparking talk of a mortgage price war. Meanwhile, China’s trade surplus topped $1 trillion for the first time after exports rose nearly 6% year-on-year in November.
8 December 2025
NIO Stock on December 8, 2025: Deliveries Surge, Shares Slide and Analysts Split on the Outlook

NIO Stock on December 8, 2025: Deliveries Surge, Shares Slide and Analysts Split on the Outlook

NIO shares traded near $5.12 in New York on December 8, 2025, down 29% over the past month despite record third-quarter deliveries of 87,071 vehicles and revenue of RMB 21.79 billion. Gross margin rose to 13.9%, but the company posted a net loss of RMB 3.48 billion, narrowing losses year over year. The stock’s price-to-sales ratio stands at 1.2x, close to the U.S. auto industry median.
Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals reported Phase 1b/2 trial data showing its AI-discovered drug REC-4881 reduced polyp burden by a median 43% at 13 weeks in patients with familial adenomatous polyposis. Shares rose as much as 6% pre-market before settling in the mid-$4 range. Most patients maintained or improved reductions after stopping treatment. No approved drugs currently exist for this condition.
Nvidia (NVDA) Stock on December 8, 2025: CUDA 13.1, Synopsys Deal and SAFE CHIPS Act Steer the Next AI Chapter

Nvidia (NVDA) Stock on December 8, 2025: CUDA 13.1, Synopsys Deal and SAFE CHIPS Act Steer the Next AI Chapter

Nvidia shares traded near $183 on December 8, 2025, following a major CUDA 13.1 software release, a $2 billion Synopsys deal, and Q3 FY26 revenue of $57 billion. The company’s market cap stands around $4.4 trillion. New U.S. export controls and China bans have heightened geopolitical risks. Wall Street’s 12-month price targets average $250–$260, with most analysts rating NVDA a “Strong Buy.”
BigBear.ai Stock (BBAI) Today: Price, Middle East Expansion, Dilution Risks and 2026 Forecast

BigBear.ai Stock (BBAI) Today: Price, Middle East Expansion, Dilution Risks and 2026 Forecast

BigBear.ai shares traded around $6.4–$6.5 on December 8, giving the company a market cap near $3 billion. The stock is up 49% year-to-date, but revenue is falling and losses continue. The company doubled its authorized share count and short interest stands near 20%. BigBear.ai opened a new office in Abu Dhabi, expanding into the Middle East.
Plug Power Stock Today: NASA Contract, Cash Lifeline and a Divided Wall Street – What December 8, 2025 Really Changes for PLUG

Plug Power Stock Today: NASA Contract, Cash Lifeline and a Divided Wall Street – What December 8, 2025 Really Changes for PLUG

Plug Power postponed its special shareholder meeting to January 29, 2026, with a new record date of December 12. Shares traded near $2.13 midday, valuing the company at about $3 billion. The firm announced its first liquid hydrogen supply contract with NASA, worth up to $2.8 million. Short interest remains high at around 30% of the float.
Ondas Holdings (ONDS) Stock on December 8, 2025: New Ukrainian Drone Deal Caps a Wild Year for This Autonomous Defense Play

Ondas Holdings (ONDS) Stock on December 8, 2025: New Ukrainian Drone Deal Caps a Wild Year for This Autonomous Defense Play

Ondas Holdings said December 8 it will invest up to $11 million in Ukraine’s Drone Fight Group, aiming to bring DFG’s combat-tested drones to U.S. and allied markets. The announcement follows a year in which Ondas’ market cap soared to $3.4 billion, with shares trading near $9.30, up over 6,500% from a year ago. Ondas plans to manufacture the drones in the U.S. and showcase them to U.S. defense and tech leaders.
HanesBrands (HBI) Stock After the Gildan Takeover: What Delisting, Deal Terms and New Forecasts Mean for Investors (Dec 8, 2025)

HanesBrands (HBI) Stock After the Gildan Takeover: What Delisting, Deal Terms and New Forecasts Mean for Investors (Dec 8, 2025)

Gildan Activewear closed its acquisition of HanesBrands on December 1, 2025, ending HBI’s status as an independent stock and triggering its delisting from the NYSE. Each HanesBrands share was exchanged for 0.102 Gildan shares plus $0.80 in cash. The deal valued HanesBrands at about $4.4 billion including debt. As of December 8, the implied value per former HBI share is approximately $6.84.
Warner Bros. Discovery Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Paramount Skydance launched a $30-per-share hostile all-cash bid for Warner Bros. Discovery on December 8, sending WBD stock up as much as 7% to near $28. The offer, valued at about $74.4 billion in equity, bypasses the board and challenges Netflix’s earlier $82.7 billion deal. Over 43 million WBD shares traded, several times normal volume. The tender offer expires in early January 2026 unless extended.
8 December 2025
Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Dyne Therapeutics shares jumped 14% to $23.20 by mid-afternoon Monday after the company reported its Phase 1/2 DELIVER trial in Duchenne muscular dystrophy met its primary endpoint. The stock touched an intraday high near $25.68 on volume over 2.5 million shares. Dyne plans to seek U.S. accelerated approval in 2026. The company reported $792 million in cash as of Q3 2025.
IBM to Acquire Confluent for $11 Billion in All‑Cash Deal to Power Enterprise AI Data Streaming

IBM to Acquire Confluent for $11 Billion in All‑Cash Deal to Power Enterprise AI Data Streaming

IBM will acquire Confluent in an all-cash deal valued at $11 billion, paying $31 per share. Both boards approved the transaction, with Confluent shareholders holding 62% of voting power backing the deal. Shares of Confluent jumped up to 30% in pre-market trading, while IBM stock slipped about 2%. The companies expect to close the deal by mid-2026, pending regulatory and shareholder approval.
Bank of Canada Expected to Hold Interest Rate at 2.25% on December 10 as Fed Prepares to Cut

Bank of Canada Expected to Hold Interest Rate at 2.25% on December 10 as Fed Prepares to Cut

The Bank of Canada is expected to hold its key interest rate at 2.25% on December 10, according to a Reuters poll of 33 economists. The U.S. Federal Reserve is widely forecast to cut its rate by 25 basis points the same day. The Bank of Canada will announce its decision at 9:45 a.m. ET, followed by a press conference at 10:30 a.m. The Canadian rate has fallen from 3.25% at the start of 2025.
CRH plc Stock: S&P 500 Debut, Buybacks and 2026 Infrastructure Tailwinds — Latest News & Forecasts (8 December 2025)

CRH plc Stock: S&P 500 Debut, Buybacks and 2026 Infrastructure Tailwinds — Latest News & Forecasts (8 December 2025)

CRH will join the S&P 500 on December 22, the company confirmed Monday. Its New York-listed shares surged in pre-market trading, jumping from $119.65 to about $128 after the announcement. London shares also hit a new 12-month high, reaching 9,602p. S&P Dow Jones Indices said CRH will replace LKQ in the quarterly rebalance.
IBM Stock After the $11 Billion Confluent Deal: Price, Forecasts and AI Strategy in December 2025

IBM Stock After the $11 Billion Confluent Deal: Price, Forecasts and AI Strategy in December 2025

IBM said December 8 it will acquire Confluent Inc. for $11 billion in cash, or $31 per share. IBM shares traded flat to slightly lower near $308 following the announcement, while Confluent jumped over 20%. The deal is expected to close by mid-2026. IBM’s market cap stands near $290 billion, with shares up more than 40% year-to-date.
GameStop (GME) Stock Today: Price, Q3 2025 Earnings Preview, Short Interest and Forecasts

GameStop (GME) Stock Today: Price, Q3 2025 Earnings Preview, Short Interest and Forecasts

GameStop shares traded near $23 midday December 8, with a market cap of $10.3 billion, ahead of its Q3 2025 earnings report on December 9. Analysts expect Q3 revenue of about $987 million and adjusted EPS of $0.20, both up from last year. Short interest remains high at 16.9% of float, with 69 million shares sold short. GameStop holds over $500 million in Bitcoin and reported a cash balance of $8.7 billion in Q2.
1 504 505 506 507 508 584
Go toTop